TVARDI THERAPEUTICS, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
TVARDI THERAPEUTICS, INC. (TVRD) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2026-03-31
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2015-09-30 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2015-06-30 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2015-03-31 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2014-09-30 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2025 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2015 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2014 was 0.00 shares.
- TVARDI THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2013 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-31 | |||
| 2015-12-31 | 0.00 shares 10-K · filed 2016-03-11 | |||
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-09 | 0.00 shares 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-11 | |||
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-09 | 0.00 shares 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | 0.00 shares 10-Q · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | |||
| 2013-12-31 | 0.00 shares 10-K · filed 2016-03-11 | |||
| 2013-06-30 | 11.25M shares 10-Q · filed 2014-08-07 | 11.26M shares 10-Q · filed 2014-08-07 | ||
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |